Thoratec centrimag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: A systematic literature review and meta-analysis of observational studies

ASAIO Journal

Volumn 60, Issue 5, 2014, Pages 487-497

  Borisenko, Oleg ^a   Wylie, Gillian ^b   Payne, John ^c   Bjessmo, Staffan ^d   Smith, Jon ^e   Yonan, Nizar ^f   Firmin, Richard ^g  

^a Synergus AB   (Sweden)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e FREEMAN HOSPITAL   (United Kingdom)

^f WYTHENSHAWE HOSPITAL   (United Kingdom)

^g GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Cardiorespiratory failure; Extracorporeal membrane oxygenation; Mechanical circulatory support; Systematic literature review; Ventricular assist device

Indexed keywords

FIBER OPTIC SENSORS; GRAFTS; HEART; OXYGENATION; RESPIRATORY THERAPY; SURGERY;

CARDIOGENIC SHOCKS; EXTRACORPOREAL MEMBRANE OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; OBSERVATIONAL STUDY; RIGHT VENTRICULAR; SYSTEMATIC LITERATURE REVIEW; SYSTEMATIC SEARCHES; VENTRICULAR ASSIST DEVICE;

LEFT VENTRICULAR ASSIST DEVICES;

BLEEDING; BLOOD PUMP; CARDIAC GRAFT REJECTION; CARDIOGENIC SHOCK; CARDIOGENIC SHOCK REFRACTORY; CARDIOPULMONARY INSUFFICIENCY; CLINICAL EFFECTIVENESS; DEVICE FAILURE; DEVICE INFECTION; EXTRACORPOREAL OXYGENATION; GERMANY; GRAFT FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEMOLYSIS; HUMAN; KIDNEY DISEASE; META ANALYSIS; METHODOLOGY; NETHERLANDS; NEUROLOGICAL COMPLICATION; PRECARDIOTOMY; PRIORITY JOURNAL; REVIEW; SEVERE CARDIOPULMONARY INSUFFICIENCY; SURVIVAL; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT DURATION; UNITED KINGDOM; UNITED STATES; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; MALE; OBSERVATIONAL STUDY; RESPIRATORY INSUFFICIENCY; SHOCK, CARDIOGENIC;

EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; OBSERVATIONAL STUDY AS TOPIC; RESPIRATORY INSUFFICIENCY; SHOCK, CARDIOGENIC;

EID: 84907018101     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000117     Document Type: Review

References (63)

1. National Institute for Health and Clinical Excellence: Short-Term Circulatory Support with Left Ventricular Assist Devices as a Bridge to Cardiac Transplantation or Recovery. IPG177. London, National Institute for Health and Care Excellence, 2006.
2. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, 4th ed. 2005, pp. 625.
3. NHS England. Service Specification. Ventricular Assist Devices (VADs) for adults as a bridge to heart transplantation or myocardial recovery, 2011.
4. NHS England. Service Specification. Ventricular Assist Devices (VADs) for children as a bridge to heart transplantation, 2011.
5. Chuang-Stein C, Beltangady M: Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies. Pharm Stat 10: 3-7, 2011.
6. Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
7. Extracorporeal Membrane Oxygenation: An Evaluation of Current Treatment Approaches in the United Kingdom (Service Evaluation), 2013, pp. 43.
8. Thomas HL, Dronavalli VB, Parameshwar J, Bonser RS, Banner NR, Audit obotSGotUCT: Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: A United Kingdom national study. Eur J Cardiothorac Surg 40: 1348-1354, 2011.
9. Hosmane S, Venkateswaran R, Salaie J, Williams S, Yonan N: Outcome of extracorporeal membrane oxygenation as short term mechanical support following heart transplantation: a single centre experience. Manchester, United Kingdom, Joint Annual Meeting of ACTA-SCTC, 2012, pp. 139.
10. De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A: Clinical performance with the Levitronix Centrimag shortterm ventricular assist device. J Heart Lung Transplant 25: 181-186, 2006.
11. De Robertis F, Rogers P, Amrani M, et al: Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant 27: 474-478, 2008.
12. Akay MH, Gregoric ID, Radovancevic R, Cohn WE, Frazier OH: Timely use of a CentriMag heart assist device improves survival in postcardiotomy cardiogenic shock. J Card Surg 26: 548-552, 2011.
13. Aziz TA, Singh G, Popjes E, et al: Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant 29: 66-71, 2010.
14. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP: Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant 28: 971-976, 2009.
15. Bindoff C, Dean R, Bashford A, et al: Mobilization and physiotherapy of patients with Levitronix CentriMag short-term mechanical circulatory support device. J Heart Lung Transplant 28: S281, 2009.
16. Bruschi G, Cannata A, Russo CF, et al: Single center experience with the Levitronix CentriMag circulation support system as short term cardiac assist in different clinical scenarios. J Heart Lung Transplant 27: S154-S155, 2008.
17. Byrnes J, McKamie W, Swearingen C, et al: Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population. ASAIO J 57: 456-461, 2011.
18. Cassidy J, Haynes S, Kirk R, et al: Changing patterns of bridging to heart transplantation in children. J Heart Lung Transplant 28: 249-254, 2009.
19. Chen JM, Richmond ME, Charette K, et al: A decade of pediatric mechanical circulatory support before and after cardiac transplantation. J Thorac Cardiovasc Surg 143: 344-351, 2012.
20. Chung DA, Kizner L, Al-Deiri M, et al: Clinical utility of the Levitronix CentriMag in extracorporeal membrane oxygenation for severe cardiogenic shock. J Heart Lung Transplant 26: S87, 2007.
21. Clough RE, Vallely MP, Henein MY, Pepper JR: Levitronix ventricular assist device as a bridge-to-recovery for post-cardiotomy cardiogenic shock. Int J Cardiol 134: 408-409, 2009.
22. den Uil CA, Maat AP, Lagrand WK, et al: Mechanical circulatory support devices improve tissue perfusion in patients with endstage heart failure or cardiogenic shock. J Heart Lung Transplant 28: 906-911, 2009.
23. Di Bella I, Ramoni E, Da Col U, et al: Is lower limb venous drainage during peripheral extracorporeal membrane oxygenation necessary? ASAIO J 56: 35-36, 2010.
24. Favaloro RR, Bertolotti A, Diez M, et al: Adequate systemic perfusion maintained by a CentriMag during acute heart failure. Tex Heart Inst J 35: 334-339, 2008.
25. Garcia JP, Kon ZN, Evans C, Wu Z IA, McCormick B, Griffith BP: Ambulatory veno-venous extracorporeal membrane oxygenation: Innovation and pitfalls. J Thorac Cardiovasc Surg 142: 755-761, 2011.
26. Gašparović H, Petričević M, Ivančan V, Miličić C, Biočina B: Initial clinical results with the Levitronix CentriMag Mechanical Assist Device at the University Hospital Rebro Zagreb. Rad Med Fak Zagrebu 36: 47-53, 2011.
27. Haj-Yahia S, Birks EJ, Amrani M, et al: Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J Thorac Cardiovasc Surg 138: 227-230, 2009.
28. Horváth V, Němec P, Ondrášek J, et al: Short-term mechanical support with the Levitronix CentriMag centrifugal pump. Cor Vasa 53: 144-147, 2011.
29. John R, Liao K, Lietz K, et al: Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 134: 351-358, 2007.
30. John R, Long JW, Massey HT, et al: Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 141: 932-939, 2011.
31. Khan N, Al-alouo M, Shad DL: Early experience with the Levitronix CentriMag device for extra corporeal membrane oxygenation following lung transplantation. Eur J Cardiothorac Surg 34:1262-1264, 2008.
32. Kouretas PC, Kaza AK, Burch PT, et al: Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artif Organs 33:1002-1004, 2009.
33. Loforte A, Montalto A, Ranocchi F, et al: Temporary mechanical circulatory support for acute cardiogenic shock. Eur J Heart Fail 9: S193-S194, 2010.
34. Loforte A, Potapov E, Krabatsch T, et al: Levitronix CentriMag to Berlin Heart Excor: A "bridge to bridge" solution in refractory cardiogenic shock. ASAIO J 55: 465-468, 2009.
35. Loforte A, Montalto A, Ranocchi F, et al: Levitronix CentriMag third-generation magnetically levitated continuous flow pump as bridge to solution. ASAIO J 57: 247-253, 2011.
36. Loforte A, Montalto A, Lilla Della Monica P, Musumeci F: Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure. Interact Cardiovasc Thorac Surg 10: 847-850, 2010.
37. Maat AP, van Thiel RJ, Dalinghaus M, Bogers AJ: Connecting the Centrimag Levitronix pump to Berlin Heart Excor cannulae; a new approach to bridge to bridge. J Heart Lung Transplant 27: 112-115, 2008.
38. Marquez TT, D'Cunha J, John R, Liao K, Joyce L: Mechanical support for acute right ventricular failure: Evolving surgical paradigms. J Thorac Cardiovasc Surg 137: e39-e40, 2009.
39. McCormick AJ, Reid BB, Budge D, et al: Versatility and patient outcomes with the levitronix centrimag temporary ventricular assist device. J Heart Lung Transplant 29: S100, 2010.
40. Meyer AL, Strueber M, Tomaszek S, et al: Temporary cardiac support with a mini-circuit system consisting of a centrifugal pump and a membrane ventilator. Interact Cardiovasc Thorac Surg 9: 780-783, 2009.
41. Morgan JA, Naseem TM, Cheema FH, et al: Improvement in survival with implantation of levitronix centrimag biventricular circulatory support in patients with acute st-elevation myocardial infarction (STEMI) and refractory cardiogenic shock. J Heart Lung Transplant 28: S143, 2009.
42. Nelson KM, Marks JD, Eidson M, et al: Initial pilot study of the Levitronix CentriMag VAS for RVAD support following LVAD implementation. ASAIO J 52: 36A, 2006.
43. Netuka I, Malý J, Szarszoi O, et al: [Technique of implantation and experience with temporary mechanical cardiac support in right ventricular failure]. Rozhl Chir 90: 88-94, 2011.
44. Pawlak S, Sliwka J, Przybylski R, et al: Peirwsze doswiadczenia w kiniczynm zastosowaniu system wsopmagania serca pompa rotacynja Levitronix. (Early experience in clinical use of mechanical ventricular assist Levitronix device). Kardiochirugia I Torakochirugia i Polska 6: 171-175, 2009.
45. Reckers J, Asfour B, Fink C: Goodbye Hemolysis! Experience with Levitronix CentriMag in 33 Newborns, Infants and Children. 54th Annual Conference of ASAIO. San Francisco, United States, 2008.
46. Russo CF, Cannata A, Lanfranconi M, et al: Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock. J Thorac Cardiovasc Surg 140: 1416-1421, 2010.
47. Santise G, Petrou M, Pepper JR, Dreyfus G, Khaghani A, Birks EJ: Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation. J Heart Lung Transplant 25: 495-498, 2006.
48. Shuhaiber JH, Jenkins D, Berman M, et al: The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant 27: 158-64, 2008.
49. Singh RK, Addonizio LJ, Richmond M, Vincent J, Torres A, Williams M: A novel approach to management of acute rejection with percutaneous ventricular assist device insertion in two adolescent heart transplant patients. J Card Fail 15: S55, 2009.
50. Soleimani B, Brehm C, Wallace S, et al: Application of new generation rotary pumps and oxygenators for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock (RCS). J Heart Lung Transplant 30: S211, 2011.
51. Stepanenko A, Pappalardo F, Scandroglio AM, Potapov EV, Krabatsch T, Hetzer R: Anticoagulation management during CentriMag right ventricular assist device support after heartmate II implantation. Heart Surg Forum 13: S113, 2010.
52. Takayama H, Chen JM, Jorde UP, Naka Y: Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg 12: 110-111, 2011.
53. Takayama H, Naka Y, Kodali SK, et al: A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardiothorac Surg 41: 423-426, 2012.
54. Westaby S, Balacumaraswami L, Evans BJ, et al: Elective transfer from cardiopulmonary bypass to centrifugal blood pump support in very high-risk cardiac surgery. J Thorac Cardiovasc Surg 133: 577-578, 2007.
55. Worku B, Naka Y PS, Cheema FH, et al: Predictors of mortality after short-term ventricular assist device placement. Ann Thorac Surg 92: 1608-1612, 2011.
56. Yang JA, Takayama H, Kim H, Cohen SA, Naka Y: Feasibility of BiVAD support with membrane oxygenation. J Heart Lung Transplant 29: S181-S182, 2010.
57. Zych B, Popov AF, Barsan A, et al: Treatment of refractory right heart failure after implantation of a left ventricular assist device. Is the levitronix centrimag right heart support a solution? Heart 97: A49, 2011.
58. Velik-Salchner C, Hoermann C, Hoefer D, Margreiter J, Mair P: Thromboembolic complications during weaning from right ventricular assist device support. Anesth Analg 109: 354-357, 2009.
59. Sims DB, Takayama H, Uriel N, Gillam LD, Naka Y, Jorde UP: Ventricular assist device-associated thrombus. Circulation 124: e197-e198, 2011.
60. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J: Thirtyyear trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population-based perspective. Circulation 119: 1211-1219, 2009.
61. Carnendran L, Abboud R, Sleeper LA, et al: Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart J 22: 472-478, 2001.
62. Cassidy J, Dominguez T, Haynes S, et al: A longer waiting game: bridging children to heart transplant with the Berlin Heart EXCOR device-The United Kingdom experience. J Heart Lung Transplant 32: 1101-1106, 2013.
63. Mohite PN, Zych B, Popov AF, et al: CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: Use beyond 30 days. Eur J Cardiothorac Surg 44: e310-e315, 2013.